Please use this identifier to cite or link to this item:
|Title:||Antimicrobial proteins from snake venoms: Direct bacterial damage and activation of innate immunity against staphylococcus aureus skin infection|
|Authors:||Samy, R.P. |
Fusidic acid ointment
|Citation:||Samy, R.P.,Stiles, B.G.,Gopalakrishnakone, P.,Chow, V.T.K. (2011-11). Antimicrobial proteins from snake venoms: Direct bacterial damage and activation of innate immunity against staphylococcus aureus skin infection. Current Medicinal Chemistry 18 (33) : 5104-5113. ScholarBank@NUS Repository. https://doi.org/10.2174/092986711797636108|
|Abstract:||The innate immune system is the first line of defense against microbial diseases. Antimicrobial proteins produced by snake venoms have recently attracted significant attention due to their relevance to bacterial infection and potential development into new therapeutic agents. Staphylococcus aureus is one of the major human pathogens causing a variety of infections involving pneumonia, toxic shock syndrome, and skin lesions. With the recent emergence of methicillin (MRSA) and vancomycin (VRSA) resistance, S. aureus infection is a serious clinical problem that will have a grave socio-economic impact in the near future. Although S. aureus susceptibility to innate antimicrobial peptides has been reported recently, the protective effect of snake venom phospholipase A2 (svPLA2) proteins on the skin from S. aureus infection has been understudied. This review details the protective function of svPLA2s derived from venoms against skin infections caused by S. aureus. We have demonstrated in vivo that local application of svPLA2 provides complete clearance of S. aureus within 2 weeks after treatment compared to fusidic acid ointment (FAO). In vitro experiments also demonstrate that svPLA2 proteins have inhibitory (bacteriostatic) and killing (bactericidal) effects on S. aureus in a dose-dependant manner. The mechanism of bacterial membrane damage and perturbation was clearly evidenced by electron microscopic studies. In summary, svPLA2s from Viperidae and Elapidae snakes are novel molecules that can activate important mechanisms of innate immunity in animals to endow them with protection against skin infection caused by S. aureus. © 2011 Bentham Science Publishers.|
|Source Title:||Current Medicinal Chemistry|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 12, 2019
checked on Jan 25, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.